A Clinical Study of Tranilast in the Treatment of Scleredema Diabeticorum
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
56 patients with scleredema diabeticorum will be selected to receive treatment of tranilast.
After a period of time ,we can determine the efficacy of the drug by detecting the the
thickness of skin before and after treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University